A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer
Abstract
miRNAs are promising biomarkers in oncology as their small size makes them less susceptible to degradation than mRNA in FFPE tissue. We aimed to derive a hypoxia-associated miRNA signature for bladder cancer.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 12, 2021
- Source ID
- 10.1038/s41416-021-01326-9
Entities
People
- Ananya Choudhury
- Brian Lane
- Catharine M. West
- David J. Mcconkey
- Helen R. Valentine
- Joely J. Irlam-jones
- Kai Aragaki
- Lars Dyrskjøt
- Mairah T. Khan
- Peter J. Hoskin
- Ronnie Rodrigues Pereira
Organizations
- United States Department of Defense